Comparative Study on Different Bone Reconstruction After Chest Wall Tumor Resection
Launched by SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE'S HOSPITAL · May 20, 2025
Trial Information
Current as of September 03, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring new ways to rebuild the chest wall after surgery for chest wall tumors. When doctors remove these tumors, it can leave a large hole in the chest wall, which is important for protecting the organs inside and keeping the chest stable. The goal of the study is to find better methods for reconstructing the bone in the chest wall to ensure it remains strong and functions well, avoiding problems like instability or fractures that can occur with current techniques.
To be eligible for this trial, participants need to be between 18 and 70 years old and have certain types of tumors in the chest area that have not spread to other parts of the body. They should also be in good overall health, without serious issues affecting their heart, lungs, liver, or kidneys. If someone joins the study, they will contribute to important research aimed at improving surgical outcomes for patients with chest wall tumors. It's important to note that the trial is not yet recruiting participants, so interested individuals will need to wait for it to begin.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. 18-70 years old, male or female not limited
- • 2. Anesthesia ASA score I-II
- • 3. Malignant tumor of soft tissue in the chest
- • 4. Malignant tumors of ribs, rib cartilage, and sternum
- • 5. Tumors with uncertain or unknown properties of ribs, rib cartilage, and sternum
- • 6. Giant benign tumors of ribs, rib cartilage, and sternum
- • 7. The preoperative examination results indicate that the tumor has not undergone distant metastasis
- • 8. Willing to participate in the research and sign the informed consent form
- Exclusion Criteria:
- • 1. Patients with distant metastasis detected during preoperative examination
- • 2. Inoperable tumor
- • 3. During the examination, it was discovered that the patient had another type of malignant tumor present
- • 4. ECOG 4
- • 5. Suffering from active or chronic fungal/bacterial/viral infections
- • 6. History of allergy to anesthesia related drugs
- • 7. Heart and lung dysfunction, liver and kidney dysfunction, inability to tolerate surgery
- • 8. Patients with mental disorders who are unable to cooperate with treatment
About Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Shanghai Jiao Tong University Affiliated Sixth People's Hospital is a leading medical institution in China, renowned for its commitment to advanced healthcare and innovative clinical research. As a prominent clinical trial sponsor, the hospital leverages its strong academic foundation and multidisciplinary expertise to conduct high-quality studies that aim to enhance therapeutic options and improve patient outcomes. The institution is dedicated to fostering collaboration between researchers, healthcare professionals, and industry partners, ensuring the rigorous application of ethical standards and scientific integrity in all its clinical trials. Through its state-of-the-art facilities and a patient-centered approach, the hospital plays a vital role in advancing medical knowledge and contributing to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported